Greg Reh – Global Life Sciences & Health Care Leader,…
Greg Reh leads Deloitte’s global life sciences sector which includes clients in biopharma, medtech, generics and distribution businesses, as well as…
Tagged with Cell and Gene Therapy
David López García – Country Manager, BioMarin Mexico
David López García, Mexico country manager of global rare genetic therapy player Biomarin, outlines the challenging situation around patient access…
David Kim – CEO, Cure Therapeutics & CureCell, South…
Cure Therapeutics is a startup developing gene and cell therapies in Korea. Its founder David Kim explains where his passion for regenerative…
Woosok Lee – CEO, Kolon Life Science; Kolon TissueGene;…
Woosok Lee, CEO of Kolon Pharma, Kolon Life Science and Kolon TissueGene, offers his insights into the potential of their blockbuster product Invossa…
BG Rhee – CEO, SCM Lifescience, South Korea
Dr BG Rhee, CEO of SCM Lifescience discusses their patented proprietary subfraction technology to extract high purity cell cultures, and the impact…
Janet Downie – CEO, Roslin CT, UK
A spinout from the Roslin Institute that created Dolly the Sheep, Roslin CT is a cell and gene therapy CDMO, with a unique positioning in the field…
Keith Thompson – CEO, Cell and Gene Therapy Catapult, UK
Keith Thompson, CEO of the Cell & Gene Therapy Catapult, one of a number of Catapult institutions in the UK designed to help commercialize…
